The Normal Phenotype of Pmm1-Deficient Mice Suggests that Pmm1 Is Not Essential for Normal Mouse Development
Authors:
- 1 August 2006
- journal article
- Published by Taylor & Francis in Molecular and Cellular Biology
- Vol. 26 (15) , 5621-5635
Abstract
Phosphomannomutases (PMMs) are crucial for the glycosylation of glycoproteins. In humans, two highly conserved PMMs exist: PMM1 and PMM2. In vitro both enzymes are able to convert mannose-6-phosphate (mannose-6-P) into mannose-1-P, the key starting compound for glycan biosynthesis. However, only mutations causing a deficiency in PMM2 cause hypoglycosylation, leading to the most frequent type of the congenital disorders of glycosylation (CDG): CDG-Ia. PMM1 is as yet not associated with any disease, and its physiological role has remained unclear. We generated a mouse deficient in Pmm1 activity and documented the expression pattern of murine Pmm1 to unravel its biological role. The expression pattern suggested an involvement of Pmm1 in (neural) development and endocrine regulation. Surprisingly, Pmm1 knockout mice were viable, developed normally, and did not reveal any obvious phenotypic alteration up to adulthood. The macroscopic and microscopic anatomy of all major organs, as well as animal behavior, appeared to be normal. Likewise, lectin histochemistry did not demonstrate an altered glycosylation pattern in tissues. It is especially striking that Pmm1, despite an almost complete overlap of its expression with Pmm2, e.g., in the developing brain, is apparently unable to compensate for deficient Pmm2 activity in CDG-Ia patients. Together, these data point to a (developmental) function independent of mannose-1-P synthesis, whereby the normal knockout phenotype, despite the stringent conservation in phylogeny, could be explained by a critical function under as-yet-unidentified challenge conditions.Keywords
This publication has 30 references indexed in Scilit:
- Targeted Disruption of the Mouse Phosphomannomutase 2 Gene Causes Early Embryonic LethalityMolecular and Cellular Biology, 2006
- Tissue distribution of the murine phosphomannomutases Pmm1 and Pmm2 during brain developmentEuropean Journal of Neuroscience, 2005
- Neurological presentation of a congenital disorder of glycosylation CDG-Ia: Implications for diagnosis and genetic counselingAmerican Journal of Medical Genetics, 2001
- Congenital disorders of glycosylation: genetic model systems lead the wayTrends in Cell Biology, 2001
- β-Trace protein in human cerebrospinal fluid: a diagnostic marker for N-glycosylation defects in brainBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1999
- Hypoglycosylation of a brain glycoprotein (β-trace protein) in CDG syndromes due to phosphomannomutase deficiency and N-acetylglucosaminyl-transferase II deficiencyGlycobiology, 1997
- Mutations in PMM2, a phosphomannomutase gene on chromosome 16p13 in carbohydrate-deficient glycoprotein type I syndrome (Jaeken syndrome)Nature Genetics, 1997
- Isolation of the Human Phosphomannomutase Gene (PMM1) and Assignment to Chromosome 22q13Genomics, 1997
- Case 4 Olivopontocerebellar Atrophy in Carbohydrate-Deficient Glycoprotein SyndromePediatric Pathology & Laboratory Medicine, 1995
- Olivopontocerebellar atrophy of neonatal onset and disialotransferrin developmental deficiency syndrome.Archives of Disease in Childhood, 1991